ACIP recommends hepatitis B vaccination for adults with diabetes

The Advisory Committee on Immunization Practices voted on Tuesday to recommend vaccination against hepatitis B for adults with diabetes under the age of 60 and said that people older than 60 may get the vaccine.
The group, which advises the U.S. Centers for Disease Control and Prevention, voted 12-2 to include diabetics in the high-risk group of unvaccinated adults that should receive the vaccination, Reuters reports. This is the first time that the panel made a hepatitis B vaccine recommendation for people with diabetes after studies showed that those under the age of 60 were more than twice as likely to get infected than people without diabetes.
The studies found no significant increase of hepatitis B in diabetics over the age of 60.
Hepatitis B is a serious disease that can turn chronic and cause liver damage or cancer. While there is no cure, the disease can be prevented with a vaccine. The CDC has recommended routine hepatitis B vaccination for children and adolescents since 1991. The recommendation also applies to adults who are unvaccinated and are at risk of getting infected, such as people with chronic liver or kidney disease, men who have sex with men, people with multiple sexual partners or whose jobs expose them to human blood.
If the CDC follows its advisers' recommendation, the list will be expanded to include people with diabetes under the age of 60. People with diabetes have been the focus of discussions about Hepatitis B vaccination for several years because studies showed their increase likelihood of getting the virus through a lack of sterility in their blood glucose monitoring.